86 / 172
Fitness for Purpose
Methods must be able to determine
mitragynine, 7-OH mitragynine, and
f
other relevant indole alkaloids o
Mitragyna spp., in a broad range of
matrices. Methods should be able to
quantitate the analytes for which
appropriate standards are available and
account for interfering compounds.
Mitragyna Speciosa
Working Group Members
•Corey Hilmas, NPA
•Joseph Betz, NIH
•Paula Brown, BCIT
•Carolyn Burdette, NIST
•Teresa Cain, FDA
•Mark Collison, ADM
•Gabriel Giancaspro, USP
•Jana Hildreth, Synutra Pure
•Jim Kababick, Flora Research Labs
•David Kennedy, Phenomenex
•Iklas Khan, University of Mississippi
•Elizabeth Mudge, BCIT
•Sanni Raju Natreon
,
•Mitzi Rettinger, Cerrilliant
•Brian Schaneberg, Starbucks
•Aniko Solyom, GAAS Corporation
•Darryl Sullivan, Covance
•James Traub, Waters
•Jason Wubben, ADM
•Garret Zielinski, Covance